Uses of dithiocarbamate compounds
AssigneeSony Corporation
InventorsFlorian VON WROCHEM, Jurina WESSELS, Dequing GAO, William FORD, Sylvia ROSSELLI, Rene WIRTZ
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of dithiocarbamate compounds and to an assembly for use in an electronic device, said assembly comprising a self-assembled monolayer of at least one dithiocarbamate compound. The present invention also relates to an electronic device including such assembly.
Claims15
Use of a dithiocarbamate compound for modifying the work function of a conducting, semiconducting, or insulating inorganic substrate.
Use according to any of the foregoing claims, wherein said dithiocarbamate compound has a permanent positive or negative electrical dipole moment.
Use according to any of the foregoing claims, wherein said dithiocarbamate compound has an S2CNH— group or an S2CNR— group in its molecular structure, wherein R denotes an alkyl, aryl, aralkyl, heteroalkyl, heteroaryl or heteroaralkyl substituent, which itself is substituted or unsubstituted.
Use according to any of the foregoing claims, wherein said dithiocarbamate compound is a piperazine dithiocarbamate derivative or a piperidine dithiocarbamate derivative.
Use according to any of the foregoing claims, wherein said dithiocarbamate compound has at least one or several uncharged polar components in its molecular structure.
Use according to any of the foregoing claims, wherein said dithiocarbamate compound is selected from the group having the general structures:
- wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- wherein EA′ denotes a bridging electron-accepting group selected from the group comprising —OC(O)—, —C(O)O—, —C(O)—, —S(O)2—, —N(R′)C(O)—, and —N(R′)S(O)2—, where R′=H or CH3, and wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- wherein EA′ denotes a bridging electron-donating group selected from the group comprising —N(R′)—, —O—, —S—, and —C(O)N(R′)—, where R′=H or CH3, and wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- piperazine (X═N) or piperidine (X═CH) derivatives having the general structures:
- wherein EA′ denotes a bridging electron-accepting group selected from the group comprising —OC(O)—, —C(O)O—, —C(O)—, and —S(O)2—, wherein ED′ denotes a bridging electron-donating group selected from the group comprising —N(R′)—, —O—, and —S—, and wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- piperazine or piperidine derivatives having the general structures:
- wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- piperazine (X═N) or piperidine (X═CH) derivatives having the general structures:
- wherein EA′ denotes a bridging electron-accepting group selected from the group comprising —OC(O)—, —C(O)O—, —C(O)—, and —S(O)2—, wherein ED′ denotes a bridging electron-donating group selected from the group comprising —N(R′)—, —O—, and —S—, and wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- benzylamine derivatives having the general structures:
- wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- tetrahydroisoquinoline or isoindoline derivatives having the general structures:
- wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group,
- aniline or diphenylamine derivatives having the general structures:
- wherein H denotes an H-atom, EA denotes an electron-accepting group, and ED denotes an electron-donating group.
Dependencies are inferred from the claim text.